Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Xue, Yan ^a   Li, Lei ^a   Zhang, Dong ^a   Wu, Kaijie ^a   Chen, Yule ^a   Zeng, Jin ^a   Wang, Xinyang ^a   He, Dalin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR TWIST; ENZYME INHIBITOR; TELOMERASE; TERT PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; TELOMERE; ANIMAL; BLADDER TUMOR; CELL CLONE; CELL MOTION; DISEASE COURSE; DOMINANT GENE; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; TELOMERE HOMEOSTASIS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CLONE CELLS; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HUMANS; MICE; MUTATION; NEOPLASM INVASIVENESS; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TWIST TRANSCRIPTION FACTOR; URINARY BLADDER NEOPLASMS;

EID: 81055125819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027748     Document Type: Article

References (41)

1. Razak ZK, Varkonyi RJ, Kulp-McEliece M, Caslini C, Testa JR, et al. (2004) p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance. Mol Cell Biol 24: 5967-5977.
2. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-5.
3. Shay JW, Bacchetti S, (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-91.
4. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR, (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-8.
5. Henson JD, Neumann AA, Yeager TR, Reddel RR, (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene 21: 598-610.
6. Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR, (2001) Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 21: 3862-75.
7. Kumakura S, Tsutsui TW, Yagisawa J, Barrett JC, Tsutsui T, (2005) Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. Cancer Res 65: 2778-86.
8. Shay JW, Wright WE, (2002) Telomerase: a target for cancer therapeutics. Cancer Cell 2: 257-65.
9. Neumann AA, Reddel RR, (2002) Telomere maintenance and cancer-look, no telomerase. Nat Rev Cancer 2: 879-84.
10. Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, et al. (2003) Alternative lengthening of telomeres and survival patients with glioblastoma multiforme. Lancet 361: 836-8.
11. Costa A, Daidone MG, Daprai L, Villa R, Cantu S, et al. (2006) Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res 66: 8918-24.
12. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-90.
13. Smit MA, Peeper DS, (2010) Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging 2: 735-741.
14. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, et al. (2008) Induction of EMT by twist protein as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14: 79-89.
15. Liu Y, EI-Naggar S, Darling DS, Higashi Y, Dean DC, (2008) Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 135: 579-88.
16. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, et al. (1996) Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5: 685-91.
17. Li L, He D, He H, Wang X, Zhang L, et al. (2006) Overexpression of PML induced apoptosis in bladder cancer cell by caspase dependent pathway. Cancer Lett 236: 259-68.
18. He D, Mu ZM, Le X, Hsieh JT, Pong RC, et al. (1997) Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells. Cancer Res 57: 1868-72.
19. Zhu G, Zhau HE, He H, Zhang L, Shehata B, et al. (2007) Sonic and desert hedgehog signaling in human fetal prostate development. Prostate 67: 674-84.
20. Stagno D'Alcontres M, Mendez-Bermudez A, Foxon JL, Royle NJ, Salomoni P, (2007) Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA. J Cell Biol 179: 855-67.
21. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, et al. (1999) Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59: 4175-9.
22. Mialhe A, Levacher G, Champelovier P, Martel V, Serres M, et al. (2000) Expression of E-, P-, n-cadherins and Catenins in human bladder carcinoma cell lines. J Urol 164: 826-35.
23. Stewart SA, Hahn WC, O'Connor BF, Banner EN, Lundberg AS, et al. (2002) Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99: 12606-11.
24. Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S, et al. (2004) Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23: 7345-54.
25. Weinberg RA, (2008) Twisted epithelial-mesenchymal transition blocks senescence. Nat Cell Biol 10: 1021-3.
26. Bacchetti S, (1996) Telomere maintenance in tumor cells. Cancer Surv 28: 197-216.
27. de Lange T, (2002) Protection of mammalian telomeres. Oncogene 21: 532-40.
28. Bechter OE, Zou Y, Walker W, Wright WE, Shay JW, (2004) Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res 64: 3444-51.
29. Chen Wei, Xiao Bo-Kui, Liu Jun-Ping, Chen Shi-Ming, Tao Ze-Zhang, (2010) Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells. Cancer Science 101: 1769-76.
30. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO, (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 13: 2388-99.
31. Delhommeau F, Thierry A, Feneux D, Lauret E, Leclercg E, et al. (2002) Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant negative hTERT mutant. Oncogene 21: 8262-71.
32. Jackson P, Grimm MO, Kingsley EA, Brosius U, Antalis T, et al. (2002) Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines. Urol Oncol 7: 99-104.
33. Thykjaer T, Christensen M, Clark AB, Hansen LR, Kunkel TA, et al. (2001) Functional analysis of the mismatch repair system in bladder cancer. Br J Cancer 85: 568-75.
34. Bertrand P, Rouillard D, Boulet A, Levalois C, Soussi T, et al. (1997) Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 14: 1117-22.
35. Elliott B, Jasin M, (2001) Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells. Mol Cell Biol 21: 2671-82.
36. Thompson EW, Williams ED, (2008) EMT and MET in carcinoma-clinical observations, regulatory pathways and new models. Clin Exp Metastasis 25: 591-2.
37. Colitz CM, Sugimoto Y, Lu P, Barden CA, Thomas-Ahner J, et al. (2009) ERα increases expression and interacts with TERT in cataractous canine lens epithelial cells. Mol Vis 15: 2259-67.
38. Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA, (2003) Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 17: 88-100.
39. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, et al. (2010) Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101: 293-9.
40. Fondrevelle ME, Kantelip B, Reiter RE, Chopin DK, Thiery JP, et al. (2009) The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking. Urol Oncol 27: 268-76.
41. Smit MA, Peeper DS, (2008) Deregulating EMT and Senescence: double impact by a single Twist. Cancer Cell 14: 5-7.